| "Bacillus dysenteriae" Shiga 1898| "Bacillus dysentericus" Shiga 1897| "Bacillus shigae" Chester 1901| "Eberthella dysenteriae" (Shiga 1898) Bergey et al. 1925| "Shigella shigae" (Chester 1901) Wilson and Miles 1946| ATCC 13313| Bacillus dysenteriae| Bacillus dysentericus| Bacillus shigae| CIP 57.28| Eberthella dysenteriae| Escherichia/Shigella dysenteriae| NCTC 4837| Shigella dysenteriae| Shigella dysenteriae (Shiga 1897) Castellani and Chalmers 1919| Shigella dysenteriae (Shiga 1898) Castellani and Chalmers 1919| Shigella shigae
Environmental Role: Flavobacterium aquatile and other members of the genus Flavobacterium are known for their diverse metabolic capabilities and their ability to degrade complex organic compounds in aquatic environments. They contribute to nutrient cycling, organic matter decomposition, and the maintenance of ecosystem balance in freshwater and marine habitats.
Biotechnological Applications: Some Flavobacterium species, including Flavobacterium aquatile, have been studied for their potential biotechnological applications, particularly in the fields of wastewater treatment, bioremediation, and aquaculture. They may have roles in the degradation of pollutants and the production of enzymes or bioactive compounds with industrial or environmental significance.
Rare Human Infections: While Flavobacterium aquatile is not considered a common human pathogen, there have been rare reports of infections in humans, typically associated with immunocompromised individuals or those with underlying medical conditions. In such cases, Flavobacterium aquatile infections may present as opportunistic infections, such as wound infections, bacteremia, or urinary tract infections.
Prevention: Preventive measures to minimize the risk of infections with Flavobacterium aquatile or other environmental bacteria include maintaining good hygiene practices, avoiding exposure to contaminated water sources, and implementing proper wound care and infection control measures, particularly in healthcare settings.
Other Sources for more information:
R2 | Slope | Tax Name | Parent Chart |
---|---|---|---|
0.590854823589325 | 0.844677746295929 | Escherichia coli | Parent Taxa |
0.5887025594711304 | 0.8847560286521912 | Shigella boydii | Parent Taxa |
0.5628537535667419 | 0.8817334175109863 | Shigella flexneri | Parent Taxa |
0.4602164924144745 | 0.799062192440033 | Escherichia albertii | Parent Taxa |
0.4587889313697815 | 0.8014569282531738 | Escherichia fergusonii | Parent Taxa |
0.43867287039756775 | 0.6872115731239319 | Escherichia sp. E4742 | Parent Taxa |
0.3513741195201874 | 0.6499959230422974 | Shigella sonnei | Parent Taxa |
0.25555530190467834 | -0.6596541404724121 | Aeromonas veronii | Parent Taxa |
R2 | Slope | Tax Name | Parent Chart |
---|---|---|---|
0.6343181133270264 | 0.9495917558670044 | Shigella boydii | Parent Taxa |
0.5882954001426697 | 0.8656174540519714 | Shigella flexneri | Parent Taxa |
0.542636513710022 | 0.5218048095703125 | Escherichia coli | Parent Taxa |
0.5292816758155823 | 0.8610333800315857 | Shigella sonnei | Parent Taxa |
0.5267517566680908 | 0.8441067934036255 | Escherichia sp. E4742 | Parent Taxa |
0.5236741900444031 | 0.8164631128311157 | Escherichia albertii | Parent Taxa |
0.4847191572189331 | 0.8053171038627625 | Escherichia fergusonii | Parent Taxa |
0.45617106556892395 | 0.7917138934135437 | Escherichia marmotae | Parent Taxa |
0.2592349052429199 | 0.4691862463951111 | Escherichia ruysiae | Parent Taxa |
0.2570154070854187 | 0.5760807394981384 | Salmonella enterica | Parent Taxa |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]